Paul Tudor Jones’s Amicus Therapeutics FOLD Stock Holding History

Paul Tudor Jones’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-37,500	Closed	-$534K	–	3848
2025 Q4	$534K	Buy	+37,500	New	+$368K	﹤0.01%	2696

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Paul Tudor Jones's FOLD Position: Q2 2026 in Review

Paul Tudor Jones sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 900,000 shares — an estimated $13M sold.

Paul Tudor Jones first reported a position in FOLD in Q3 2014 and held it in 28 quarters. The position peaked at $13M in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

Paul Tudor Jones reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
Paul Tudor Jones sold 900,000 Amicus Therapeutics shares in Q2 2026, an estimated $13M.
Paul Tudor Jones first reported a position in Amicus Therapeutics in Q3 2014 and held it in 28 quarters.
Paul Tudor Jones's Amicus Therapeutics position peaked at $13M in Q1 2026.
2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.